本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Context Therapeutics Inc.

1.00
+0.05635.97%
盘后0.9500-0.0500-5.00%19:53 EDT
成交量:36.60万
成交额:34.79万
市值:8,970.42万
市盈率:-2.19
高:1.02
开:0.9900
低:0.8399
收:0.9437
数据加载中...
2022/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/23

重要事件披露

8-K - Current report
2022/03/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/10

重要事件披露

8-K - Current report
2022/01/05

重要事件披露

8-K - Current report
2021/12/14

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/10

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/11/01

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/11/01

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/25

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/25

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/25

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/22

重要事件披露

8-K - Current report
2021/10/20

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/18

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/18

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/10/15

SEC问询函

CORRESP [Cover] - Correspondence